Cargando…
Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma
Lung cancer is one of the leading causes of cancer-associated death, with the etiology largely unknown. The aim of this study was to identify key driver genes with therapeutic potentials in lung adenocarcinoma (LUAD). Transcriptome microarray data from four GEO datasets (GEO: GSE7670, GSE10072, GSE6...
Autores principales: | Yang, Haoran, Jiang, Peng, Liu, Dongyan, Wang, Hong-Qiang, Deng, Qingmei, Niu, Xiaojie, Lu, Li, Dai, Haiming, Wang, Hongzhi, Yang, Wulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477516/ https://www.ncbi.nlm.nih.gov/pubmed/31024988 http://dx.doi.org/10.1016/j.omto.2019.03.012 |
Ejemplares similares
-
Targeted Inhibition of LPL/FABP4/CPT1 fatty acid metabolic axis can effectively prevent the progression of nonalcoholic steatohepatitis to liver cancer
por: Yang, Haoran, et al.
Publicado: (2021) -
Matrix Metalloproteinase Expressions Play Important role in Prediction of Ovarian Cancer Outcome
por: Wang, Shujie, et al.
Publicado: (2019) -
A prediction model for prognosis of gastric adenocarcinoma based on six metabolism-related genes
por: Zhao, Jingyu, et al.
Publicado: (2023) -
The Tumorigenic Effect of the High Expression of Ladinin-1 in Lung Adenocarcinoma and Its Potential as a Therapeutic Target
por: Hu, Lei, et al.
Publicado: (2023) -
Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)